[The] identification of Pompe disease mutations in archival tissues and development of a rapid molecular-based test
SQUMJ-Sultan Qaboos University Medical Journal. 2013; 13 (4): 502-509
em Inglês
| IMEMR
| ID: emr-128691
ABSTRACT
Pompe disease [glycogen storage disease type II] is a rare autosomal recessive lysosomal storage disease that is caused by acid alpha-glucosidase deficiency. Early enzyme replacement therapy can benefit infants with the disease but the diagnosis is complicated by the rarity of the disease and the heterogeneity of the clinical manifestations. In this study, DNA extracted from archival postmortem formalin-fixed paraffin-embedded tissues was used to identify Pompe disease mutations in Oman and develop a rapid molecular-based test. Intronic primers were designed to amplify short fragments [193-454 base pairs [bp]] from coding exons [2-20] and screen for mutations using direct sequencing [DS]. Two mutations known to cause severe disease were identified in two samples. One was a coding mutation, c.2560C>T [p.Arg854X], and the second was found at a splice acceptor site, c.1327-2A>G. Polymerase chain reaction- and restriction fragment length polymorphism-based tests were designed for the rapid genotyping of the identified mutations. These tests can facilitate prenatal diagnosis and help in identifying carriers in families with the identified mutations
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Diagnóstico Pré-Natal
/
Análise Mutacional de DNA
/
Predisposição Genética para Doença
/
Sítios de Splice de RNA
/
Alfa-Glucosidases
/
Terapia de Reposição de Enzimas
/
Mutação
Limite:
Feminino
/
Humanos
/
Masculino
Idioma:
Inglês
Revista:
Sultan Qaboos Univ. Med. J.
Ano de publicação:
2013
Similares
MEDLINE
...
LILACS
LIS